Latest BHVN Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Edmund Ingham | Forbes | Initiates Coverage | Buy | - | |
| Dina Ramadane | BofA Securities | Reiterates | Sell | $11.00 | |
| Tyler Van Buren | TD Cowen | Maintains | Buy | $30.00 | |
| Leonid Timashev | RBC Capital | Maintains | Buy | $22.00 → $23.00 +1.00 (4.5%) | |
| stockpicker63 | StockTwits | Initiates Coverage | Buy | - | |
| MarketsParadise | StockTwits | Initiates Coverage | Buy | - | |
| Tessa Romero | JP Morgan | Maintains | Buy | - | |
| Tessa Romero | JP Morgan | Maintains | Buy | - | |
| Dina Ramadane | BofA Securities | Downgrades | Sell | $12.00 → $11.00 -1.00 (-8.3%) | |
| David Hoang | Deutsche Bank | Reiterates | Buy | $15.00 → $20.00 +5.00 (33.3%) | |
| Christopher Raymond | Raymond James | Maintains | Buy | - | |
| Leonid Timashev | RBC Capital | Maintains | Buy | $22.00 | |
| Christopher Raymond | Raymond James | Maintains | Buy | - | |
| Anthropic Biotechnology | TipRanks - Anthropic | Reiterates | Hold | $13.50 → $15.00 +1.50 (11.1%) | |
| Sumant Kulkarni | Canaccord Genuity | Reiterates | Buy | $21.00 |
